Publications by authors named "A Ibnidris"

Background: The Target Product Profile (TPP) is a tool used in industry to guide development strategies by addressing user needs and fostering effective communication among stakeholders. However, they are not frequently used in academic research, where they may be equally useful. This systematic review aims to extract the features of accessible TPPs, to identify commonalities and facilitate their integration in academic research methodology.

View Article and Find Full Text PDF

Background: A core element of the Strengthening Responses to Dementia in Developing Countries (STRiDE) programme was to generate novel data on the prevalence, cost and impact of dementia in low- and middle-income countries, to build better health policy. Indonesia and South Africa are two middle-income countries in need of such data.

Aims: To present the STRiDE methodology and generate estimates of dementia prevalence in Indonesia and South Africa.

View Article and Find Full Text PDF
Article Synopsis
  • A study utilizing a Delphi process with eight experts aimed to provide more accurate dementia prevalence estimates in India, highlighting the variability in previous studies.
  • The consensus reached indicated a dementia prevalence rate of 2.8% among individuals aged 60 and older, with a notable portion living with mild severity.
  • The findings suggest there could be around 3.9 million individuals with dementia in India, which is crucial for research, policy making, and resource allocation regarding dementia care.
View Article and Find Full Text PDF

Background: Subjective cognitive decline (SCD) is present in the early stage of preclinical Alzheimer's disease (AD) and is associated with an increased risk of further cognitive decline and AD dementia later in life. Early detection of at-risk groups with subjective complaints is critical for targeted dementia prevention at the earliest. Accurate assessment of SCD is crucial.

View Article and Find Full Text PDF

Background: Alzheimer's disease (AD) pathology is present many years before the onset of clinical symptoms. AD dementia cannot be treated. Timely and early detection of people at risk of developing AD is key for primary and secondary prevention.

View Article and Find Full Text PDF